2nd ESMO consensus conference on lung cancer : early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up

Autoria(s): Vansteenkiste, J.; Crinò, L.; Dooms, C.; Douillard, J.Y.; Faivre-Finn, C.; Lim, E.; Rocco, G.; Senan, S.; van Schil, P.; Veronesi, G.; Stahel, R.; Peters, S.; Felip, E.; Kerr, K.; Besse, B.; Eberhardt, W.; Edelman, M.; Mok, T.; O'Byrne, K.; Novello, S.; Bubendorf, L.; Marchetti, A.; Baas, P.; Reck, M.; Syrigos, K.; Paz-Ares, L.; Smit, E.; Meldgaard, P.; Adjei, A.; Nicolson, M.; Weder, W.; de Ruysscher, D.; Le Pechoux, C.; de Leyn, P.; Westeel, V.
Data(s)

01/11/2014
Resumo

To complement the existing treatment guidelines for all tumour types, ESMO organises consensus conferences to focus on specific issues in each type of tumour. The 2nd ESMO Consensus Conference on Lung Cancer was held on 11-12 May 2013 in Lugano. A total of 35 experts met to address several questions on non-small-cell lung cancer (NSCLC) in each of four areas: pathology and molecular biomarkers, first-line/second and further lines in advanced disease, earlystage disease and locally advanced disease. For each question, recommendations were made including reference to the grade of recommendation and level of evidence. This consensus paper focuses on early-stage disease. © The Author 2014. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved.
Identificador

http://eprints.qut.edu.au/78355/
Publicador

Oxford University Press
Relação

DOI:10.1093/annonc/mdu089

Vansteenkiste, J., Crinò, L., Dooms, C., Douillard, J.Y., Faivre-Finn, C., Lim, E., Rocco, G., Senan, S., van Schil, P., Veronesi, G., Stahel, R., Peters, S., Felip, E., Kerr, K., Besse, B., Eberhardt, W., Edelman, M., Mok, T., O'Byrne, K., Novello, S., Bubendorf, L., Marchetti, A., Baas, P., Reck, M., Syrigos, K., Paz-Ares, L., Smit, E., Meldgaard, P., Adjei, A., Nicolson, M., Weder, W., de Ruysscher, D., Le Pechoux, C., de Leyn, P., & Westeel, V. (2014) 2nd ESMO consensus conference on lung cancer : early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up. Annals of Oncology, 25(8), pp. 1462-1474.
Fonte

School of Biomedical Sciences; Faculty of Health; Institute of Health and Biomedical Innovation
Palavras-Chave #111200 ONCOLOGY AND CARCINOGENESIS #Consensus #Early disease #ESMO #Lung cancer #Non-small-cell lung cancer #cisplatin #fluorodeoxyglucose #navelbine #adjuvant therapy #article #bronchus stenosis #cancer adjuvant therapy #cancer radiotherapy #cancer risk #cancer screening #cancer staging #cancer surgery #cardiopulmonary exercise test #clinical assessment #comorbidity #computer assisted tomography #consensus development #coughing #European Society for Medical Oncology #fatigue #follow up #health care organization #hemoptysis #high risk population #human #incidence #low dose computed tomography #lung non small cell cancer #necrosis #positron emission tomography #priority journal #radiation pneumonia #randomized controlled trial (topic) #rib fracture #risk assessment #skin irritation #stereotactic ablative radiotherapy #stereotactic treatment #tumor volume #video assisted thoracoscopic surgery
Tipo

Journal Article
Acesso ao item digital